extensive metabolizers

Related by string. * exten sive . ex tensive . EXTENSIVE . Extensive : extensive pretrial publicity . extensive artisanal workings . Extensive searches . Extensive renovations . extensive rework Gimble . Outsourcing Extensive / : slowest metabolizers plus . slow caffeine metabolizers . ultra rapid metabolizers . fast metabolizers . poor metabolizers . slow metabolizers * *

Related by context. Frequent words. (Click for all words.) 63 multivariate analyzes 62 confidence interval #.#-#.# 61 T2DM 61 P = .# 61 p = .# [002] 61 antibiotic prophylaxis 60 % CI #.#-#.# [007] 60 lipid lowering therapy 60 % CI #.#-#.# [003] 59 CI #.#-#.# [002] 59 CI -#.# 59 univariate analysis 59 PCa 59 concomitant medications 59 QTc 58 MetS 58 CYP#D# 58 thromboembolic 58 rheumatoid factor 58 HRQoL 58 prognostic factors 57 confidence interval CI 57 serum concentrations 57 PsA 57 nonobese 57 comorbidity 57 comorbid conditions 57 symptomatology 57 % CI #.#-#.# [006] 57 nonresponders 57 left ventricular systolic 57 transurethral resection 57 LUTS 57 serum PSA 57 lipid lowering drugs 57 EBRT 57 univariate 56 reperfusion therapy 56 atopic 56 thromboembolic events 56 neoadjuvant 56 epithelial ovarian cancer 56 prepubertal 56 sulfasalazine 56 stable angina 56 prevalences 56 postop 56 biochemical recurrence 56 preoperatively 56 vertebral fracture 56 comorbidities 55 angiotensin converting enzyme inhibitors 55 adenocarcinomas 55 juvenile idiopathic arthritis 55 antibody titers 55 histopathological 55 ischemic cardiomyopathy 55 VUR 55 HSCT 55 subgroup analyzes 55 sd = 55 TURP 55 D dimer 55 varicocele 55 nondiabetic 55 HRQOL 55 multivariate analysis 55 breast carcinoma 55 HbA 1c 55 LVEF 55 nonadherence 55 titers 54 thromboembolism 54 statistically significant p = 54 liver transplant recipients 54 substudy 54 serum testosterone 54 hypomagnesemia 54 pg ml 54 comorbid 54 hsCRP 54 irbesartan 54 coronary angiography 54 apolipoprotein B 54 thrombolytic therapy 54 preoperative 54 microalbuminuria 54 coronary revascularization 54 nonoperative 54 HBsAg 54 somatic symptoms 54 estrogen receptor ER 54 thyroid dysfunction 54 Secondary endpoints included 54 left ventricular dysfunction 54 systolic BP 54 ADAS cog 54 NHANES III 54 neoadjuvant chemotherapy 54 lipid profiles 54 unfractionated heparin

Back to home page